GB201908171D0 - Compounds - Google Patents

Compounds

Info

Publication number: GB201908171D0
Authority: GB; United Kingdom
Prior art keywords: compounds
Prior art date: 2019-06-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1908171.0A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa

Original Assignee

Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-06-07

Filing date

2019-06-07

Publication date

2019-07-24

2019-06-07 Application filed by Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa filed Critical Instituto De Medicina Molecular Faculdade De Medicina Univ De Lisboa

2019-06-07 Priority to GBGB1908171.0A priority Critical patent/GB201908171D0/en

2019-07-24 Publication of GB201908171D0 publication Critical patent/GB201908171D0/en

2020-06-05 Priority to EP20732523.4A priority patent/EP3980126A1/en

2020-06-05 Priority to CN202080054085.5A priority patent/CN114206867A/en

2020-06-05 Priority to AU2020288706A priority patent/AU2020288706A1/en

2020-06-05 Priority to CA3140767A priority patent/CA3140767A1/en

2020-06-05 Priority to PCT/EP2020/065730 priority patent/WO2020245430A1/en

Status Ceased legal-status Critical Current

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
GBGB1908171.0A GB201908171D0 (en)	2019-06-07	2019-06-07	Compounds
EP20732523.4A EP3980126A1 (en)	2019-06-07	2020-06-05	Benzo[h][1,6] naphthyridin-2(1h)-ones as bmx inhibitors, for use against cancer
CN202080054085.5A CN114206867A (en)	2019-06-07	2020-06-05	Benzo[H][1,6]naphthyridin-2(1H)-ones as BMX inhibitors for the fight against cancer
AU2020288706A AU2020288706A1 (en)	2019-06-07	2020-06-05	Benzo[h][1,6] naphthyridin-2(1H)-ones as BMX inhibitors, for use against cancer
CA3140767A CA3140767A1 (en)	2019-06-07	2020-06-05	Benzo[h][1,6] naphthyridin-2(1h)-ones as bmx inhibitors, for use against cancer
PCT/EP2020/065730 WO2020245430A1 (en)	2019-06-07	2020-06-05	Benzo[h][1,6] naphthyridin-2(1h)-ones as bmx inhibitors, for use against cancer

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1908171.0A GB201908171D0 (en)	2019-06-07	2019-06-07	Compounds

Publications (1)

Publication Number	Publication Date
GB201908171D0 true GB201908171D0 (en)	2019-07-24

Family

ID=67386187

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1908171.0A Ceased GB201908171D0 (en)	2019-06-07	2019-06-07	Compounds

Country Status (6)

Country	Link
EP (1)	EP3980126A1 (en)
CN (1)	CN114206867A (en)
AU (1)	AU2020288706A1 (en)
CA (1)	CA3140767A1 (en)
GB (1)	GB201908171D0 (en)
WO (1)	WO2020245430A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115124524A (en) *	2021-03-26	2022-09-30	浙江海正药业股份有限公司	Tricyclic derivative and preparation method and application thereof
US12030883B2 (en) *	2021-09-21	2024-07-09	Incyte Corporation	Hetero-tricyclic compounds as inhibitors of KRAS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013154778A1 (en)	2012-04-11	2013-10-17	Dana-Farber Cancer Institute, Inc.	Host targeted inhibitors of dengue virus and other viruses
WO2014063054A1 (en)	2012-10-19	2014-04-24	Dana-Farber Cancer Institute, Inc.	Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
CN104829610B (en) *	2014-06-20	2017-03-15	中国科学院合肥物质科学研究院	A kind of novel cloth Shandong tyrosine kinase inhibitor

2019
- 2019-06-07 GB GBGB1908171.0A patent/GB201908171D0/en not_active Ceased
2020
- 2020-06-05 EP EP20732523.4A patent/EP3980126A1/en not_active Withdrawn
- 2020-06-05 CN CN202080054085.5A patent/CN114206867A/en active Pending
- 2020-06-05 CA CA3140767A patent/CA3140767A1/en active Pending
- 2020-06-05 AU AU2020288706A patent/AU2020288706A1/en not_active Abandoned
- 2020-06-05 WO PCT/EP2020/065730 patent/WO2020245430A1/en not_active Ceased

Also Published As

Publication number	Publication date
CN114206867A (en)	2022-03-18
EP3980126A1 (en)	2022-04-13
CA3140767A1 (en)	2020-12-10
AU2020288706A1 (en)	2022-01-06
WO2020245430A1 (en)	2020-12-10

Publication	Publication Date	Title
IL289463A (en)	2022-02-01	Gipr-agonist compounds
GB201913603D0 (en)	2019-11-06	New compounds
GB201905721D0 (en)	2019-06-05	Compounds
GB201910305D0 (en)	2019-09-04	Compounds
GB201916915D0 (en)	2020-01-01	Compounds
GB201908536D0 (en)	2019-07-31	Compounds
GB201912404D0 (en)	2019-10-16	New compounds
GB201910304D0 (en)	2019-09-04	Compounds
GB201908171D0 (en)	2019-07-24	Compounds
GB201908095D0 (en)	2019-07-24	Carboxy-MIDA-boronate compounds
GB201919205D0 (en)	2020-02-05	Compounds
GB201918761D0 (en)	2020-01-29	Compounds
GB201918424D0 (en)	2020-01-29	Compounds
GB201917891D0 (en)	2020-01-22	Compounds
GB201917893D0 (en)	2020-01-22	Compounds
GB201917895D0 (en)	2020-01-22	Compounds
GB201916847D0 (en)	2020-01-01	Compounds
GB201916595D0 (en)	2020-01-01	Compounds
GB201916597D0 (en)	2020-01-01	Compounds
GB201916572D0 (en)	2020-01-01	Compounds
GB201916142D0 (en)	2019-12-18	Compounds
GB201914208D0 (en)	2019-11-13	Compounds
GB201913633D0 (en)	2019-11-06	Compounds
GB201913541D0 (en)	2019-11-06	Compounds
GB201912850D0 (en)	2019-10-23	Compounds

Legal Events

Date	Code	Title	Description
2021-02-03	AT	Applications terminated before publication under section 16(1)